MetaCap

Compass Therapeutics Insider Trades

NASDAQ: CMPXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

0.6882+0.0097 (+1.43%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
5 · $102.75K
Sales
0 · $0
Shares bought / sold
72.50K / 0
Net activity
Net buying $102,750

Compass Therapeutics insider activity

Over the last 12 months, Compass Therapeutics insiders reported 13 transactions on SEC Form 4: 5 open-market purchases and 0 sales. Insiders bought $102,750 and sold $0 worth of stock, for net insider buying of $102,750. The most recent filing shows Lerner Neil (Chief Accounting Officer) buying 10,000 shares at $0.59 on Nov 17, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put CMPX's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

CMPX insider transactions

Compass Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Nov 17, 2026Lerner NeilChief Accounting OfficerBuy10,000$5.90KForm 4
Oct 1, 2026Lerner NeilChief Accounting OfficerBuy20,000$18.40KForm 4
Sep 24, 2026Lerner NeilChief Accounting OfficerBuy2,500$2.85KForm 4
Apr 29, 2026Lerner NeilChief Accounting OfficerAward15,000$28.35KForm 4
Apr 29, 2026Anderman JonathanGeneral CounselAward25,000$47.25KForm 4
Apr 29, 2026Anderman JonathanGeneral CounselBuy25,000$47.25KForm 4
Apr 29, 2026Lerner NeilChief Accounting OfficerBuy15,000$28.35KForm 4
Feb 8, 2026Schuetz Thomas J.CHIEF EXECUTIVE OFFICERTax withholding36,687$239.20KForm 4
Jan 9, 2026Schuetz Thomas J.CHIEF EXECUTIVE OFFICERTax withholding46,777$250.26KForm 4
Jan 2, 2026Anderman JonathanGeneral CounselAward150,000$775.50KForm 4
Jan 2, 2026Lerner NeilChief Accounting OfficerAward62,500$323.13KForm 4
Jan 2, 2026Shin BarryCFOAward125,000$646.25KForm 4
Jan 2, 2026Schuetz Thomas J.CEOAward250,000$1.29MForm 4
Nov 16, 2025Schuetz Thomas J.CHIEF EXECUTIVE OFFICERTax withholding44,025$212.64KForm 4
May 27, 2025Schuetz Thomas J.CHIEF EXECUTIVE OFFICERBuy10,000$21.10KForm 4
Apr 9, 2025ORBIMED ADVISORS LLC & OrbiMed Capital GP VI LLC & OrbiMed Genesis GP LLCDirectorSale3,571,428$5.68MForm 4
Apr 9, 2025GORDON CARL LDirectorSale3,571,428$5.68MForm 4
Apr 7, 2025Lerner NeilCHIEF ACCOUNTING OFFICERBuy20,000$28.40KForm 4
Apr 7, 2025Anderman JonathanGen Counsel & Corporate SecBuy20,000$30.80KForm 4
Feb 8, 2025Schuetz Thomas J.CEOTax withholding41,687$145.90KForm 4
Jan 9, 2025Schuetz Thomas J.CEOTax withholding58,054$107.98KForm 4
Dec 9, 2024Shin BarryCFOAward400,000$660.00KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related